ABM HSA Mirna inhibitor

hsa miR miRNA Inhibitor ABM – Antibody-Antibodies

Background

Non-coding RNAs and significantly microRNAs have been discovered to behave as grasp regulators of most cancers initiation and growth. The intention of our analysis was to search out and characterize the carry out of however functionally uncharacterized microRNAs in human breast carcinogenesis.

miRNA inhibitors block miRNA regulation of objective gene expression by safe suppression and would possibly knock down native miRNA expression in cells. They are often utilized in miRNA loss-of-function analysis, miRNA objective web page identification and validation, and miRNA screening experiments. abm‘s Lentivirus miRNA Inhibitors allow for safe, long term expression of miRNA inhibitors out of your cell line.

Key Choices

  • We offer a gaggle of miRNA Inhibitors for knockdown of over 5000 miRNAs from human, mouse, and rat.
  • Lentiviral provide for integration of genetic supplies into host cells, inflicting safe, long term gene expression.
  • Lentivirus has a broad host fluctuate and would possibly infect every dividing and non-dividing cells, allowing gene provide to all types of cell types.

For gene regulation and helpful analysis, abm presents a variety of expression strategies for:

  1. siRNA: successfully categorical any objective siRNA to knockdown any gene with out the need to design hair-pin loop shRNA constructions, obtainable in lentivirus, AAV and Adenovirus.
  2. miRNA: inhibit or over-express any miRNA for analysis of post-transcriptional gene regulation in mammalian strategies using our ready-to-use viral vectors and packaged viruses, along with our detection and quantification devices.
  3. UTR Reporters: quantitatively analysis a selected miRNA’s regulation of its objective gene using our 3’UTR or 5’UTR platform, all obtainable as a library of premade lentiviral vectors and lentiviruses for any human, mouse or rat gene.
abm hsa mirna inhibitor
abm hsa mirna inhibitor

Methods

In an unbiased technique, we utilized a longtime model system for breast most cancers (BC) stem cell formation (“mammosphere assay”) to ascertain full miRNome alterations in breast carcinogenesis. Medical samples of BC victims had been used to evaluate the human relevance of the newly acknowledged miRNA candidates. One promising candidate, miR-1287-5p, was extra explored on its impression on plenty of hallmarks of most cancers. The molecular mode of movement was characterised by full transcriptome analysis, in silico prediction devices, miRNA-interaction assays, pheno-copy assays, and drug sensitivity assays.

hsa-miR-9 miRNA Inhibitor

MIH03924 2 x 5.0 nmol
EUR 211.2

hsa-miR-16 miRNA Inhibitor

MIH01377 2 x 5.0 nmol
EUR 211.2

hsa-miR-17 miRNA Inhibitor

MIH01381 2 x 5.0 nmol
EUR 211.2

hsa-miR-21 miRNA Inhibitor

MIH01533 2 x 5.0 nmol
EUR 211.2

hsa-miR-22 miRNA Inhibitor

MIH01581 2 x 5.0 nmol
EUR 211.2

hsa-miR-24 miRNA Inhibitor

MIH01615 2 x 5.0 nmol
EUR 211.2

hsa-miR-25 miRNA Inhibitor

MIH01621 2 x 5.0 nmol
EUR 211.2

hsa-miR-30* miRNA Inhibitor

MIH01661 2 x 5.0 nmol
EUR 211.2

hsa-miR-31 miRNA Inhibitor

MIH01705 2 x 5.0 nmol
EUR 211.2

hsa-miR-32 miRNA Inhibitor

MIH01853 2 x 5.0 nmol
EUR 211.2

hsa-miR-93 miRNA Inhibitor

MIH03936 2 x 5.0 nmol
EUR 211.2

hsa-miR-95 miRNA Inhibitor

MIH03958 2 x 5.0 nmol
EUR 211.2

hsa-miR-96 miRNA Inhibitor

MIH03963 2 x 5.0 nmol
EUR 211.2

hsa-miR-98 miRNA Inhibitor

MIH03966 2 x 5.0 nmol
EUR 211.2

hsa-miR-100 miRNA Inhibitor

MIH01027 2 x 5.0 nmol
EUR 211.2

hsa-miR-101 miRNA Inhibitor

MIH01030 2 x 5.0 nmol
EUR 211.2

hsa-miR-103 miRNA Inhibitor

MIH01033 2 x 5.0 nmol
EUR 211.2

hsa-miR-105 miRNA Inhibitor

MIH01038 2 x 5.0 nmol
EUR 211.2

hsa-miR-107 miRNA Inhibitor

MIH01047 2 x 5.0 nmol
EUR 211.2

hsa-miR-122 miRNA Inhibitor

MIH01083 2 x 5.0 nmol
EUR 211.2

Leave a Comment

Your email address will not be published.